Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Capricor Therapeutics (CAPR)
NASDAQ:CAPR
Capricor Therapeutics (CAPR) Stock Price & Analysis
629 Followers
CAPR Stock Chart & Stats
Day’s Range$5 - $5.65
52-Week Range― - ―
Previous Close$4.82
Volume919.73K
Average Volume (3M)N/A
Market Cap
$151.84M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 09, 2024EPS Estimate
-$0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$26.00Price Target Upside415.87% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Capricor Therapeutics News
Ownership Overview
36.82% Insiders
4.75% Mutual Funds
4.42% Other Institutional Investors
54.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CAPR FAQ
What was Capricor Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Capricor Therapeutics’s market cap?
Currently, no data Available
When is Capricor Therapeutics’s upcoming earnings report date?
Capricor Therapeutics’s upcoming earnings report date is May 09, 2024 which is in 14 days.
How were Capricor Therapeutics’s earnings last quarter?
Capricor Therapeutics released its earnings results on Feb 29, 2024. The company reported -$0.02 earnings per share for the quarter, beating the consensus estimate of -$0.09 by $0.07.
Is Capricor Therapeutics overvalued?
According to Wall Street analysts Capricor Therapeutics’s price is currently Undervalued.
Does Capricor Therapeutics pay dividends?
Capricor Therapeutics does not currently pay dividends.
What is Capricor Therapeutics’s EPS estimate?
Capricor Therapeutics’s EPS estimate is -$0.11.
How many shares outstanding does Capricor Therapeutics have?
Currently, no data Available
What happened to Capricor Therapeutics’s price movement after its last earnings report?
Capricor Therapeutics reported an EPS of -$0.02 in its last earnings report, beating expectations of -$0.09. Following the earnings report the stock price went up 8.571%.
Which hedge fund is a major shareholder of Capricor Therapeutics?
Among the largest hedge funds holding Capricor Therapeutics’s share is Woodline Partners LP. It holds Capricor Therapeutics’s shares valued at 4M.
---
Capricor Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$26.00 (415.87% Upside)
$26.00 (415.87% Upside)
Blogger Sentiment
Bullish
CAPR Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 1.9M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $22.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.9%
Last 30 Days ▼ 15.9%
Last 30 Days ▼ 15.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
16.99%
12-Months-Change
Fundamentals
Return on Equity
-129.63%
Trailing 12-Months
Asset Growth
17.25%
Trailing 12-Months
Company Description
Capricor Therapeutics
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA.
---
CAPR Earnings Call
Q4 2024
0:00 / 0:00
---
CAPR Stock 12 Months Forecast
Average Price Target
$26.00
▲(415.87% Upside)
Technical Analysis
Best Analysts Covering CAPR
1 Year
1 Year Success Rate
9/12 ratings generated profit
1 Year Average Return
+17.32%
reiterated a buy rating 2 months ago
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +17.32% per trade.
---